{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:16:42Z","timestamp":1788333402643,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Good syndrome (GS) is a rare acquired immunodeficiency disorder characterized by thymoma, hypogammaglobulinemia, and peripheral B-cell lymphopenia. Because of its rarity and complexity, the diagnosis and treatment of this condition remain inadequately reported in clinical practice. Therefore, we report a typical case of GS in a patient who developed chronic diarrhea and recurrent pneumonia several years after thymectomy, with the aim of improving the understanding and early recognition of this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 55-year-old Chinese woman presented with chronic diarrhea and recurrent severe pneumonia, which developed 3 and 6 years, respectively, after thymectomy for a mixed-type (B2\/B3) thymoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Laboratory examination results revealed severe hypogammaglobulinemia (immunoglobulin G = 3.9\u2009g\/L), peripheral blood B-cell lymphopenia (B lymphocytes 12 cells\/\u03bcL), and cellular immune dysfunction (CD4+\/CD8+ ratio 0.31, CD(16\u2005+\u200556): 0.23%, CD19: 3.31%). The diagnosis was confirmed based on the combination of clinical manifestations, laboratory findings, and imaging examinations. GS was diagnosed based on the triad of thymoma history, humoral and cellular immunodeficiency, and recurrent opportunistic infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient received long-term intravenous immunoglobulin (IVIG) replacement therapy, prophylactic antibiotics, and aggressive management of acute infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Despite regular IVIG therapy, the patient\u2019s condition progressively deteriorated over 8 years, and the patient ultimately died at home, likely due to respiratory failure secondary to severe pulmonary infection (the family declined an autopsy).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case highlights that GS can manifest several years after thymectomy, necessitating sustained clinical vigilance. This case also highlights the limitations of conventional IVIG therapy and underscores the need to enhance clinicians\u2019 awareness of GS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049404","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:01:50Z","timestamp":1784322110000},"page":"e49404","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A case report of Good syndrome: Diarrhea and dyspnea"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8060-5423","authenticated-orcid":false,"given":"Qingqing","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Affiliated People\u2019s Hospital of Ningbo University, Ningbo, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfa","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated People\u2019s Hospital of Ningbo University, Ningbo, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated People\u2019s Hospital of Ningbo University, Ningbo, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated People\u2019s Hospital of Ningbo University, Ningbo, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260902","first-page":"245","article-title":"A clinical and experimental study of agammaglobulinemia.","volume":"75","author":"Good","year":"1955","journal-title":"J Lancet"},{"key":"R2-20260902","first-page":"005480","article-title":"Good\u2019s syndrome revealed by recurrent sigmoid diverticulitis.","volume":"12","author":"Attout","year":"2025","journal-title":"Eur J Case Rep Internal Med"},{"key":"R3-20260902","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1164\/rccm.202211-2159IM","article-title":"Good\u2019s syndrome: thymoma with acquired immunodeficiency.","volume":"208","author":"Koo","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20260902","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clim.2010.01.006","article-title":"Good\u2019s syndrome remains a mystery after 55 years: a systematic review of the scientific evidence.","volume":"135","author":"Kelesidis","year":"2010","journal-title":"Clin Immunol"},{"key":"R5-20260902","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1503\/cmaj.251022","article-title":"A 69-year-old man with good syndrome: thymoma-associated immunodeficiency.","volume":"198","author":"Salimi","year":"2026","journal-title":"CMAJ"},{"key":"R6-20260902","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s43152-025-00061-0","article-title":"An overview of latest developments in DLBCL its pathogenesis, immune significance, prognosis and targets.","volume":"6","author":"Sarode","year":"2025","journal-title":"Curr Tissue Microenviron Rep"},{"key":"R7-20260902","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.4049\/jimmunol.1400620","article-title":"SHP-1 plays a crucial role in CD40 signaling reciprocity.","volume":"193","author":"Khan","year":"2014","journal-title":"J Immunol"},{"key":"R8-20260902","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.4049\/jimmunol.1900311","article-title":"IL-11 induces encephalitogenic Th17 cells in multiple sclerosis and experimental autoimmune encephalomyelitis.","volume":"203","author":"Zhang","year":"2019","journal-title":"J Immunol"},{"key":"R9-20260902","doi-asserted-by":"crossref","first-page":"e2221007120","DOI":"10.1073\/pnas.2221007120","article-title":"IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system.","volume":"120","author":"Seyedsadr","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-20260902","doi-asserted-by":"crossref","first-page":"1138145","DOI":"10.3389\/fimmu.2023.1138145","article-title":"Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy.","volume":"14","author":"Tarique","year":"2023","journal-title":"Front Immunol"},{"issue":"Pt 3","key":"R11-20260902","doi-asserted-by":"crossref","first-page":"126823","DOI":"10.1016\/j.ijbiomac.2023.126823","article-title":"Characterization of pH-induced conformational changes in recombinant DENV NS2B-NS3pro.","volume":"253","author":"Hisamuddin","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"R12-20260902","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/cancers16234095","article-title":"Sirtuins as key regulators in pancreatic cancer: insights into signaling mechanisms and therapeutic implications.","volume":"16","author":"Chouhan","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R13-20260902","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/ijms26010183","article-title":"Molecular sentinels: unveiling the role of sirtuins in prostate cancer progression.","volume":"26","author":"Chouhan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R14-20260902","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s43152-024-00055-4","article-title":"The role of cancer-specific target antigens in CAR T-cell therapy in hematological malignancies.","volume":"5","author":"Khan","year":"2024","journal-title":"Curr Tissue Microenviron Rep"},{"key":"R15-20260902","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1177\/0300060519854913","article-title":"Improvement of Good\u2019s syndrome by fecal microbiota transplantation: the first case report.","volume":"47","author":"Jagessar","year":"2019","journal-title":"J Int Med Res"},{"key":"R16-20260902","doi-asserted-by":"crossref","first-page":"e9024","DOI":"10.1002\/ccr3.9024","article-title":"Good\u2019s syndrome combined with CMV gastroenteritis: a case report and literature review.","volume":"12","author":"Li","year":"2024","journal-title":"Clin Case Rep"},{"key":"R17-20260902","first-page":"328","article-title":"Good\u2019s syndrome combined with bronchiectasis: a case report and literature review.","volume":"46","author":"Ren","year":"2021","journal-title":"Zhong Nan Xue Xue Bao"},{"key":"R18-20260902","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/apm.13351","article-title":"Good\u2019s syndrome: brief overview of an enigmatic immune deficiency.","volume":"131","author":"Sipos","year":"2023","journal-title":"APMIS"},{"key":"R19-20260902","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.4103\/0366-6999.208234","article-title":"Characteristics of Good\u2019s syndrome in China: a systematic review.","volume":"130","author":"Dong","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"R20-20260902","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1157\/13045197","article-title":"Good\u2019s syndrome and chronic diarrhea.","volume":"26","author":"Puebla Maestu","year":"2003","journal-title":"Gastroenterol Hepatol"},{"key":"R21-20260902","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10875-014-0014-7","article-title":"Good\u2019s syndrome and pure white cell aplasia complicated by cryptococcus infection: a case report and review of the literature.","volume":"34","author":"Akinosoglou","year":"2014","journal-title":"J Clin Immunol"},{"key":"R22-20260902","doi-asserted-by":"crossref","first-page":"33","DOI":"10.14309\/crj.2013.13","article-title":"Beware of the patient with thymectomy: Good\u2019s syndrome in a patient presenting with diarrhea.","volume":"1","author":"Liu","year":"2013","journal-title":"ACG Case Rep J"},{"key":"R23-20260902","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1515\/med-2021-0256","article-title":"Clinicopathologic features of Good\u2019s syndrome: two cases and literature review.","volume":"16","author":"Chen","year":"2021","journal-title":"Open Med"},{"key":"R24-20260902","first-page":"56","article-title":"Case report and literature review on Good\u2019s syndrome, a form of acquired immunodeficiency associated with thymomas.","volume":"72","author":"Joven","year":"2013","journal-title":"Hawai\u2019i J Med Public Health"},{"key":"R25-20260902","doi-asserted-by":"crossref","first-page":"817100","DOI":"10.3389\/fendo.2022.817100","article-title":"Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome.","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol"},{"key":"R26-20260902","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/med-22-12","article-title":"Good\u2019s syndrome and COVID-19: case report and literature review.","volume":"7","author":"Berzenji","year":"2023","journal-title":"Mediastinum"},{"key":"R27-20260902","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.4081\/cp.2019.1112","article-title":"Good\u2019s syndrome, a rare form of acquired immunodeficiency associated with thymomas.","volume":"9","author":"Tamburello","year":"2019","journal-title":"Clin Pract"},{"key":"R28-20260902","doi-asserted-by":"crossref","first-page":"5993628","DOI":"10.1155\/2023\/5993628","article-title":"Efficacy of faecal microbiota transplantation for the treatment of autism in children: meta-analysis of randomised controlled trials.","volume":"2023","author":"Zhu","year":"2023","journal-title":"Evid Based Complement Alternative Med"},{"key":"R29-20260902","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/biomedicines11020294","article-title":"Crosstalk between gut microbiota and host immunity: impact on inflammation and immunotherapy.","volume":"11","author":"Campbell","year":"2023","journal-title":"Biomedicines"},{"key":"R30-20260902","doi-asserted-by":"crossref","first-page":"e0006022","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal microbiota transplantation: current challenges and future landscapes.","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"R31-20260902","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-med-111717-122956","article-title":"Clinical application and potential of fecal microbiota transplantation.","volume":"70","author":"Ooijevaar","year":"2019","journal-title":"Annu Rev Med"},{"key":"R32-20260902","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.4110\/in.2025.25.e10","article-title":"Aromatic amino acid metabolites: molecular messengers bridging immune-microbiota communication.","volume":"25","author":"Shin","year":"2025","journal-title":"Immune Netw"},{"key":"R33-20260902","doi-asserted-by":"crossref","first-page":"1710733","DOI":"10.3389\/fimmu.2025.1710733","article-title":"Gut microbiota-derived metabolites modulate Treg\/Th17 balance: novel therapeutic targets in autoimmune diseases.","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"R34-20260902","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/cimb47010008","article-title":"Mechanisms and emerging regulators of neuroinflammation: exploring new therapeutic strategies for neurological disorders.","volume":"47","author":"Kim","year":"2024","journal-title":"Curr Issues Mol Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:00:21Z","timestamp":1788332421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":34,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049404","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"2026-01-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}